Sortases act as transacylases that accept a wide range of substrates. Staphylococcus aureus sortase A and its derivatives recognize an LPXTG motif in their substrates, cleave it between the Thr and Gly residues with concomitant formation of a covalent thioacylenzyme intermediate, and then resolve the intermediate in a nucleophilic attack by a stretch of exposed NH2-terminal Gly residues as part of a modified short peptide or even a protein. Such modification of proteins, referred to as 'sortagging' and further developed in the PI's laboratory, has enabled the installation of a variety of different chemical modifications, including fluorophores, nucleic acids, lipids, 'click' handles, and radioisotopes. This application exploits the unique properties of sortase to address two major unsolved questions in immunobiology at a molecular and at an organismal level, the solutions to which have wide biological and biomedical implications. The dynamics of the B cell receptor for antigen (BCR) have been difficult to explore for lack of reagents that track the BCR without eliciting activation. Cas9/CRISPR genome editing experiments have yielded mice in which the immunoglobulin C? locus has been modified with an in-frame COOH-terminal LPETG motif, so that its ? light chains can be modified site-specifically in a sortase-catalyzed reaction with fluorophores suitable for F rster resonance energy transfer (FRET) measurements and stochastic optical reconstruction microscopy (STORM). Site-specific modification of the BCR at sites away from its antigen binding sites provides an unprecedented opportunity to analyze the nanoscale organization of the BCR on the surface of living B cells, both at rest and in response to antigen. Our model will enable us to explore the fate of the BCR and B cell responses and reconcile published findings that support seemingly contradictory models. Resolving this issue is of fundamental importance to understand how the BCR works. This will be pursued in Aim 1. Non-invasive imaging of an immune response in an intact mouse or human is a key goal to track sites of incipient and ongoing inflammation, to visualize an anti-viral response, or to follo initiation, execution or suppression of an anti-tumor immune response. Camelid-derived single domain antibodies (VHHs) possess a short circulatory t1/2 and superior tissue penetration. Owing to their small size (~15 kDa), VHHs are ideal vehicles for non-invasive imaging of their targets by positron emission tomography (PET). Synthetic routes to the installation of 18F and 64Cu applied to sortase-tag equipped Class II MHC-specific VHHs have yielded the first PET-imaging-ready labeled VHHs. These clearly reveal sites of inflammation, and based on these encouraging preliminary data, this approach will now be extended in Aim 2 to imaging T cells in the course of an immune response both in influenza and tumor models, using newly developed T-cell specific VHHs, labeled with either 18F or 64Cu.

Public Health Relevance

The present application has as its main goals to visualize aspects of an immune response that have previously been beyond reach. We shall study the behavior on a nanoscale of the antigen specific receptor on B cells; and at the other end of the extreme; we shall visualize an ongoing immune response non- invasively in intact mice using new tools developed in the preceding funding period.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI087879-08
Application #
9393544
Study Section
Clinical Molecular Imaging and Probe Development (CMIP)
Program Officer
Huntley, Clayton C
Project Start
2010-03-15
Project End
2020-02-29
Budget Start
2016-12-01
Budget End
2017-02-28
Support Year
8
Fiscal Year
2016
Total Cost
$1,770
Indirect Cost
$770
Name
Boston Children's Hospital
Department
Type
Independent Hospitals
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Ingram, Jessica R; Dougan, Michael; Rashidian, Mohammad et al. (2017) PD-L1 is an activation-independent marker of brown adipocytes. Nat Commun 8:647
Bardhan, Neelkanth M; Kumar, Priyank V; Li, Zeyang et al. (2017) Enhanced Cell Capture on Functionalized Graphene Oxide Nanosheets through Oxygen Clustering. ACS Nano 11:1548-1558
Bachran, Christopher; Schröder, Matthias; Conrad, Lena et al. (2017) The activity of myeloid cell-specific VHH immunotoxins is target-, epitope-, subset- and organ dependent. Sci Rep 7:17916
Hanke, Leo; Schmidt, Florian I; Knockenhauer, Kevin E et al. (2017) Vesicular stomatitis virus N protein-specific single-domain antibody fragments inhibit replication. EMBO Rep 18:1027-1037
Dongre, Anushka; Rashidian, Mohammad; Reinhardt, Ferenc et al. (2017) Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. Cancer Res 77:3982-3989
Chen, Guan-Yu; Li, Zeyang; Duarte, Joao N et al. (2017) Rapid capture and labeling of cells on single domain antibodies-functionalized flow cell. Biosens Bioelectron 89:789-794
Van Elssen, Catharina H M J; Rashidian, Mohammad; Vrbanac, Vladimir et al. (2017) Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease. J Nucl Med 58:1003-1008
Rashidian, Mohammad; Ingram, Jessica R; Dougan, Michael et al. (2017) Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells. J Exp Med 214:2243-2255
Chahal, Jasdave S; Fang, Tao; Woodham, Andrew W et al. (2017) An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model. Sci Rep 7:252
Ingram, Jessica R; Blomberg, Olga S; Sockolosky, Jonathan T et al. (2017) Localized CD47 blockade enhances immunotherapy for murine melanoma. Proc Natl Acad Sci U S A 114:10184-10189

Showing the most recent 10 out of 54 publications